GlassScriptPhysician profile
Toby Ishizuka
NPI 1942731021
$7,407.64
in general payments reported to CMS, 2019-2025
25 companies · $299 in 2025
The $299 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $77.68 · 2021: $523 · 2022: $3,066 · 2023: $1,725 · 2024: $1,717 · 2025: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,464 · Travel and Lodging: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,464.04 |
| Travel and Lodging | $277.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,435.01 | 2021-2024 | Prophecy, Easyfuse, Ortholoc 3di |
| Saxum Surgical, INC. | $1,268.60 | 2022-2023 | |
| Arthrex, INC. | $907.32 | 2024 | |
| Biotissue Holdings INC. | $742.66 | 2021-2024 | |
| Medtronic, INC. | $714.31 | 2022-2024 | Accurian |
| Paratek Pharmaceuticals, INC. | $418.69 | 2022-2024 | Nuzyra |
| Smith+Nephew, INC. | $318.75 | 2021-2023 | Collagenase Santyl, Grafix Pl |
| Orthofix Medical, INC. | $264.00 | 2024-2025 | Physio-Stim, Tl-Hex Truelok Hexapod System |
| Integra Lifesciences Corporation | $193.26 | 2022-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Paragon 28, INC. | $179.62 | 2021-2024 | Portfolio, Grappler, Jaws |
| Inari Medical, INC. | $169.59 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bioventus LLC | $161.92 | 2021-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Horizon Therapeutics Plc | $110.29 | 2022-2023 | Krystexxa |
| Ibsa Pharma INC. | $82.27 | 2023 | Licart, Tirosint, Licart |
| Zimmer Biomet Holdings, INC. | $77.68 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $56.26 | 2021-2022 | |
| Nevro Corp. | $47.87 | 2022 | |
| Sebela Pharmaceuticals INC. | $47.61 | 2022-2023 | Naftin |
| Mimedx Group, INC. | $47.30 | 2024-2025 | |
| Kci USA, INC. | $42.21 | 2021-2023 | Activ.A.C. |
| Organogenesis INC. | $35.32 | 2024 | |
| Novo Nordisk INC | $30.45 | 2024 | Ozempic, Rybelsus |
| Ani Pharmaceuticals, INC. | $22.29 | 2025 | Oxistat |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.95 | 2022 | |
| Amgen INC. | $15.41 | 2024 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Toby Ishizuka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.